T cell receptor beta variable 4-2 (TRBV4-2)

T cell receptor beta variable 4-2 (TRBV4-2) encodes the variable region of the beta chain of the T cell receptor (TCR), a crucial receptor for antigen recognition present on the surface of T lymphocytes[6][5][7]. The beta chain variable region, including TRBV4-2, is generated through somatic V(D)J recombination, enabling T cells to recognize a vast diversity of antigenic peptides presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells[1][6]. Engagement of the alpha-beta TCR with the peptide-MHC complex initiates intracellular signaling via the associated CD3 complex, activating downstream kinases and pathways (such as LCK, ZAP70, MAPK, NF-κB)[6]. TRBV4-2 is part of a large family of TCR beta variable genes, each conferring distinct antigen specificity to individual T cell clones. The structural and functional diversity provided by TRBV4-2 and related segments is essential for the adaptive immune response and is relevant to the pathogenesis of immune-mediated diseases, cancer, and infectious diseases[1][6].\n\n**TRBV4-2 is not itself a drug target but is part of the TCR, which is a therapeutic target in immuno-oncology (e.g., TCR-engineered T cells). Drugs or biologics that interact directly and specifically with TRBV4-2 are not currently known, but TCRs are broadly targeted in T cell–based therapies.**

Other names

TRBV4-2TCRBV7S3A2TCRBV7S3A2TTRBV42TCRBV4S2V segment translation product